Cell Metabolism
Volume 14, Issue 1, 6 July 2011, Pages 21-32
Journal home page for Cell Metabolism

Article
Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways

https://doi.org/10.1016/j.cmet.2011.06.002Get rights and content
Under an Elsevier user license
open archive

Summary

Through unknown mechanisms, insulin activates the sterol regulatory element-binding protein (SREBP1c) transcription factor to promote hepatic lipogenesis. We find that this induction is dependent on the mammalian target of rapamycin (mTOR) complex 1 (mTORC1). To further define the role of mTORC1 in the regulation of SREBP1c in the liver, we generated mice with liver-specific deletion of TSC1 (LTsc1KO), which results in insulin-independent activation of mTORC1. Surprisingly, the LTsc1KO mice are protected from age- and diet-induced hepatic steatosis and display hepatocyte-intrinsic defects in SREBP1c activation and de novo lipogenesis. These phenotypes result from attenuation of Akt signaling driven by mTORC1-dependent insulin resistance. Therefore, mTORC1 activation is not sufficient to stimulate hepatic SREBP1c in the absence of Akt signaling, revealing the existence of an additional downstream pathway also required for this induction. We provide evidence that this mTORC1-independent pathway involves Akt-mediated suppression of Insig2a, a liver-specific transcript encoding the SREBP1c inhibitor INSIG2.

Highlights

► mTORC1 is required for proper activation of hepatic SREBP1c by insulin ► LTsc1KO mice reveal that mTORC1 activation is not sufficient to induce hepatic SREBP1c ► An mTORC1-independent pathway is also required for hepatic SREBP1c induction by Akt ► Akt signaling suppresses Insig2a, a liver-specific inhibitor of SREBP1c

Cited by (0)

3

Present address: Joslin Diabetes Center, Boston, MA 02115, USA

4

Present address: Department of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA

5

These authors contributed equally to this work